3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hematologic Neoplasms
2
Pancreatic Neoplasms
1
Pain, Postoperative
1
Pain, Intractable
1
Neoplasms
1
Neoplasm Metastasis
1
Mucositis
1
Malignant Female Reproductive System Neoplasm
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Duodenal Neoplasms
1
Digestive System Diseases
1
Carcinoma, Hepatocellular
1
Bone Marrow Failure Disorders
1
Anemia, Aplastic
1
Agnosia
1
Interventions
Bupivacaine
4
Saline Solution
3
Ketamine
3
Transcutaneous Electric Nerve Stimulation
2
Ropivacaine
2
Radiofrequency Ablation
2
Magnesium Sulfate
2
Ketorolac
2
Dexmedetomidine
2
Control Groups
2
Anesthesia, Local
2
Acupuncture Therapy
2
Acetaminophen
2
engage 8200
1
Yoga
1
Varenicline
1
Transdermal Patch
1
Therapeutics
1
Telemedicine
1
Surgical Instruments
1
STAMP-I protocol
1
Radiosurgery
1
Psilocybin
1
Palliative Care
1
Oxycodone
1
Music Therapy
1
Morphine
1
Methods
1
Levobupivacaine
1
Ketoprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Hydromorphone
×
1 year
×
Clear all
NCT03715517
2026-02-05
SAFER-L
University of Manitoba
Phase NA
Recruiting
128 enrolled